Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Frey

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Journal of Medical Systems|June 26, 2026
Calibration of Self-Reported Confidence and Accuracy of Large Language Models in Medical Question AnsweringSebastian Daniel Boie, Florian Reis, Nicolas Frey, et al.
Clinical Pharmacology and Therapeutics|August 8, 2021
Optimized Alectinib Dose Regimen for Treatment of Patients With ALK-Positive Non-Small Cell Lung Cancer Based on Robust Pharmacometric Analyses and Clinical EvidenceNicolas Frey, Walter Bordogna, Bogdana Balas, et al.
Clinical Pharmacology and Therapeutics|January 31, 2022
Disease Modeling and Model-Based Meta-Analyses to Define a New Direction for a Phase III Program of Gantenerumab in Alzheimer's DiseaseSylvie Retout, Ronald Gieschke, Daniel Serafin, et al.
FEMS Microbiology Letters|July 12, 2003
The HPr(Ser) kinase of Streptococcus salivarius: a hexameric bifunctional enzyme controlled by glycolytic intermediates and inorganic phosphateNicolas Frey, Sylvie Nessler, Sonia Fieulaine, et al.
Clinical Pharmacokinetics|March 12, 2021
Exposure-Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIIIFredrik Jonsson, Christophe Schmitt, Claire Petry, et al.
Translational Vision Science & Technology|June 10, 2021
A Baseline Score to Predict Response to Ranibizumab Treatment in Neovascular Age-Related Macular DegenerationCheikh Diack, Dietmar Schwab, Valerie Cosson, et al.
Joint Commission Journal on Quality and Patient Safety|April 7, 2026
Validation of the Charité Alarm Fatigue Questionnaire (CAFQa-Eng) for Use with English-Speaking Critical Care CliniciansHalley Ruppel, Elena Hinz, Nicolas Frey, et al.
Studies in Health Technology and Informatics|May 17, 2025
Assessing Healthcare Stakeholder Understanding of Machine Learning DocumentationNicolas Frey, Louis Agha-Mir-Salim, Elena Hinz, et al.
Studies in Health Technology and Informatics|August 23, 2024
Integrating FHIR and UMLS in an Intelligent Tutoring SystemNicolas Frey, Nina Haffer, Lennart Vogelsang, et al.
Journal of Clinical Pharmacology|April 23, 2013
A model-based approach to predict longitudinal HbA1c, using early phase glucose data from type 2 diabetes mellitus patients after anti-diabetic treatmentMaria C Kjellsson, Valérie F Cosson, Norman A Mazer, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Journal of Medical Systems|June 26, 2026
Calibration of Self-Reported Confidence and Accuracy of Large Language Models in Medical Question AnsweringSebastian Daniel Boie, Florian Reis, Nicolas Frey, et al.
Clinical Pharmacology and Therapeutics|August 8, 2021
Optimized Alectinib Dose Regimen for Treatment of Patients With ALK-Positive Non-Small Cell Lung Cancer Based on Robust Pharmacometric Analyses and Clinical EvidenceNicolas Frey, Walter Bordogna, Bogdana Balas, et al.
Clinical Pharmacology and Therapeutics|January 31, 2022
Disease Modeling and Model-Based Meta-Analyses to Define a New Direction for a Phase III Program of Gantenerumab in Alzheimer's DiseaseSylvie Retout, Ronald Gieschke, Daniel Serafin, et al.
FEMS Microbiology Letters|July 12, 2003
The HPr(Ser) kinase of Streptococcus salivarius: a hexameric bifunctional enzyme controlled by glycolytic intermediates and inorganic phosphateNicolas Frey, Sylvie Nessler, Sonia Fieulaine, et al.
Clinical Pharmacokinetics|March 12, 2021
Exposure-Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIIIFredrik Jonsson, Christophe Schmitt, Claire Petry, et al.
Translational Vision Science & Technology|June 10, 2021
A Baseline Score to Predict Response to Ranibizumab Treatment in Neovascular Age-Related Macular DegenerationCheikh Diack, Dietmar Schwab, Valerie Cosson, et al.
Joint Commission Journal on Quality and Patient Safety|April 7, 2026
Validation of the Charité Alarm Fatigue Questionnaire (CAFQa-Eng) for Use with English-Speaking Critical Care CliniciansHalley Ruppel, Elena Hinz, Nicolas Frey, et al.
Studies in Health Technology and Informatics|May 17, 2025
Assessing Healthcare Stakeholder Understanding of Machine Learning DocumentationNicolas Frey, Louis Agha-Mir-Salim, Elena Hinz, et al.
Studies in Health Technology and Informatics|August 23, 2024
Integrating FHIR and UMLS in an Intelligent Tutoring SystemNicolas Frey, Nina Haffer, Lennart Vogelsang, et al.
Journal of Clinical Pharmacology|April 23, 2013
A model-based approach to predict longitudinal HbA1c, using early phase glucose data from type 2 diabetes mellitus patients after anti-diabetic treatmentMaria C Kjellsson, Valérie F Cosson, Norman A Mazer, et al.
Pageof 6